Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorr

Showing results (191-200 of 1,439) with videos related to

Pageof 144
Sort By:
Cancer Treatment Reports|November 1, 1981
Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compoundsR T Dorr, D S Alberts
Deutsche Medizinische Wochenschrift (1946)|April 18, 1980
[Asymptomatic haematuria (author's transl)]R Fischer, E Berg, S Dorr
Journal of Cancer Research and Clinical Oncology|January 1, 1989
H2-antagonists and carmustineR T Dorr, M J Soble
Poultry Science|September 1, 1971
Effects of aging and dietary ascorbic acid on tissue ascorbic acid in the domestic henP E Dorr, C F Nockels
Anticancer Research|January 1, 1988
Lack of enhanced antitumor efficacy for L-buthionine sulfoximine in combination with carmustine, cyclophosphamide, doxorubicin or melphalan in miceM J Soble, R T Dorr
Journal of Clinical Ultrasound : JCU|June 1, 1991
Congenital kyphosis due to absence of two lumbar vertebral bodiesB A Broekman, J P Dorr
Cancer|August 15, 1992
Topical absorption and inactivation of cytotoxic anticancer agents in vitroR T Dorr, D S Alberts
Current Opinion in Chemical Biology|February 4, 2019
Proteomic-based approaches to cardiac development and diseaseKerry M Dorr, Frank L Conlon
Nucleosides, Nucleotides & Nucleic Acids|December 28, 2002
Synthesis and biological evaluation of endocyclic 2',3'-didehydro-2',3'-dideoxymethanocarba adenosineDanaè R Quirk Dorr, Robert Vince
Investigational New Drugs|January 1, 1983
Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluentsR T Dorr, D S Alberts
Pageof 144

Showing results (191-200 of 1,439) with videos related to

Sort By:
Pageof 144
Cancer Treatment Reports|November 1, 1981
Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compoundsR T Dorr, D S Alberts
Deutsche Medizinische Wochenschrift (1946)|April 18, 1980
[Asymptomatic haematuria (author's transl)]R Fischer, E Berg, S Dorr
Journal of Cancer Research and Clinical Oncology|January 1, 1989
H2-antagonists and carmustineR T Dorr, M J Soble
Poultry Science|September 1, 1971
Effects of aging and dietary ascorbic acid on tissue ascorbic acid in the domestic henP E Dorr, C F Nockels
Anticancer Research|January 1, 1988
Lack of enhanced antitumor efficacy for L-buthionine sulfoximine in combination with carmustine, cyclophosphamide, doxorubicin or melphalan in miceM J Soble, R T Dorr
Journal of Clinical Ultrasound : JCU|June 1, 1991
Congenital kyphosis due to absence of two lumbar vertebral bodiesB A Broekman, J P Dorr
Cancer|August 15, 1992
Topical absorption and inactivation of cytotoxic anticancer agents in vitroR T Dorr, D S Alberts
Current Opinion in Chemical Biology|February 4, 2019
Proteomic-based approaches to cardiac development and diseaseKerry M Dorr, Frank L Conlon
Nucleosides, Nucleotides & Nucleic Acids|December 28, 2002
Synthesis and biological evaluation of endocyclic 2',3'-didehydro-2',3'-dideoxymethanocarba adenosineDanaè R Quirk Dorr, Robert Vince
Investigational New Drugs|January 1, 1983
Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluentsR T Dorr, D S Alberts
Pageof 144